SubscribeLogin
Published

OptimizeRx (NASDAQ:OPRX) Earns Outperform Rating from William Blair

Summary by tickerreport.com
OptimizeRx (NASDAQ:OPRX – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other equities research analysts also recently issued reports on the stock. Royal Bank of Canada lowered their price target on shares of OptimizeRx from $14.00 […]
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Bill BlairBill Blair
Stock MarketsStock Markets
United StatesUnited States
US EconomyUS Economy
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal